Mergers & Acquisitions


Current filters:


Popular Filters

829 to 853 of 914 results

ViroPharma buys option to acquire Meritage Pharma


ViroPharma (Nasdaq: VPHM) has entered into an exclusive option to acquire fellow USA based Meritage Pharma,…

BudesonideMergers & AcquisitionsMeritage PharmaPharmaceuticalRare diseasesResearchViroPharma

Lundbeck divests three branded injectables to Akorn


Danish CNS drug specialist Lundbeck (LUND: DC) says it has entered into an agreement with USA-based niche…

AkornCogentinDiurilGenericsLundbeckMergers & AcquisitionsNembutalNeurologicalNorth AmericaPharmaceutical

OPKO Health buys API developer


Miami, USA-based OPKO Health (NYSE: OPK), which is controlled by Israeli generics giant Teva Pharmaceutical…

FineTech PharmaceuticalGenericsMergers & AcquisitionsOPKO HealthTeva Pharmaceutical Industries

Covis acquires US rights for GlaxoSmithKline brands


Covis Pharma, a Switzerland-based specialty pharmaceutical company owned by affiliates of Cerberus Capital…

Covis PharmaGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

GlaxoSmithKline divests batch of OTC brands for $660 million, but still more to go


The widely expected sale of UK pharma giant GlaxoSmithKline (LSE: GSK) non-prescription brands was confirmed…

GlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Zydus Cadila acquires Mumbai-based Biochem


Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top…

Antibiotics and Infectious diseasesAsia-PacificBiochemGenericsMergers & AcquisitionsZydus Cadila

Takeda boosts oncology pipeline with acquisition


Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502), via a US subsidiary, has entered into…

IntellikineMergers & AcquisitionsOncologyPharmaceuticalTakeda Pharmaceuticals

Acino buys more Cephalon/Mepha businesses


Swiss branded and generic drugmaker Acino Pharma (SIX: ACIN) and Israel’s Teva Pharmaceutical Industries…

Acino PharmaCephalonGenericsMephaMergers & AcquisitionsTeva Pharmaceutical Industries

Covidien to spin off pharmaceuticals business


US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals…

CovidienGenericsMergers & AcquisitionsNeurologicalPharmaceutical

FTC stipulates divestments for Valeant acquisitions


Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Baxter to acquire Synovis


The USA’s Baxter International (NYSE: BAX) said yesterday that it has reached agreement to acquire…

Baxter InternationalMergers & AcquisitionsPharmaceuticalSynovis Life Technologies

Actelion pulls out of Trophos option


Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Sinclair IS buys derma company


UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

AstraZeneca expands in China, cuts back in USA


It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Generic strategic alliances


The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public…

GenericsMergers & Acquisitions

Roche acquires Verum Diagnostica for 11 million euros


Swiss drugs and diagnostics major Roche (ROG: SIX) has signed an agreement under which it will acquire…

Mergers & AcquisitionsPharmaceuticalRocheVerum Diagnostica

US Biotech scores wins in November, despite global economic turmoil, says Burrill


Economic and political worries in Europe and the USA fuelled another month of wild gyrations in the stock…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaResearch

Actavis acquires Dutch company PharmaPack


Iceland-headquartered generic drugmaker Actavis says it has acquired 100% of the shares in PharmaPack…

ActavisGenericsMergers & AcquisitionsPharmaPack

Further push into diagnostics as Affymetrix acquires eBioscience for $330 million


USA-based Affymetrix (Nasdaq: AFFX) is taking another move into diagnostics, saying that it has signed…

AffymetrixeBioscienceMergers & AcquisitionsPharmaceutical

Further $100 million committed to AstraZeneca’s MedImmune Ventures


Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday that it has committed an additional…

AstraZenecaFinancialMedImmuneMergers & AcquisitionsPharmaceutical

USA’s SOHM acquires Novatrend to expand presence in India


California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business…

Asia-PacificDermatologicalsGenericsMergers & AcquisitionsNovatrend MedicamentPharmaceuticalSOHM

Asahi Kasei Pharma expands into USA with acquisition of Artisan Pharma


Mid-size Japanese drugmaker Asahi Kasei Pharma says it has acquired its US licensee Artisan Pharma, establishing…

Artisan PharmaAsahi KaseiMergers & AcquisitionsPharmaceuticalRecomodulin

829 to 853 of 914 results

Back to top